PIK3CA and central nervous system cancer: To date, only one study has investigated PIK3CA mutation rates across all glioma molecular subtypes defined by the 2016 WHO classification, using a large cohort of 394 adult diffuse gliomas, albeit only analyzing exons 10 and 21 [29].